Multiple attempts have been made to combine Vhl loss with other cooperating genetic events, either by breeding or, more recently, by somatic gene editing with CRISPR/Cas9, in hopes of creating a murine model of human VHL–/– ccRCC (43, 51–56). The gene discussed is VHL; the disease is nonpapillary renal cell carcinoma.